Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

70 results about "2-keto-L-gulonic acid" patented technology

Method for improving production capacity of 2-KGA (2-keto-L-gulonic acid) through enhancement of Ketogulonogeniumvulgarum carbon metabolism level

The invention discloses a method which enhances glycometabolism efficiency of Ketogulonogeniumvulgarum, increases the number of bacteria, greatly shortens the incubation period of 2-KGA (2-keto-L-gulonic acid) and improves the production efficiency by adding carbon sources including two-carbon units such as ethyl alcohol, acetaldehyde and acetic acid as well as six-carbon units such as D-sorbitol, D-mannitol and D-mannose which facilitates utilization of Ketogulonogeniumvulgarum in a mixed fermentation process of a vitamin C two-step fermentation method according to research results of Ketogulonogeniumvulgarum metabolic network analysis. In a 5L fermentation tank, the period can be shortened by 14.04%, and the yield is increased by 3.40 %. According to another application, L-sorbose is taken as a carbon source by reducing Ketogulonogeniumvulgarum, so that the efficiency for converting L-sorbose into 2-KGA is also improved. According to the method, the production process is advanced, the raw material cost is low, and the method is suitable for large-scale industrial production and is improvement and promotion of vitamin C preparation technology with a biological fermentation method in about forty years of China; and besides, harmful substance emission in a production process is prevented, pollution and public hazard to the ambient environment are avoided, and environment protection requirements are met.
Owner:SHENYANG PHARMA UNIVERSITY

2-keto-l-gulonic acid high concentration fermentation production technology

The invention discloses a production technique of 2-keto-L-gulonic acid by high concentration fermentation. In a fermentation medium adopted by the production technique, the initial sorbin concentration is 15mg/ml to 25mg/ml; fermentation is carried out for 4 hours to 8 hours; continuous sorbin feeding is started; fermentation is carried out for 36 hours to 44 hours and then sorbin feeding is finished; during the feeding process, the content of sorbin is controlled to be 15 mg/ml to 30 mg/ml; when fermentation is carried out for 24 hours to 40 hours, pH value is adjusted to be 7.1 to 7.3; when fermentation is carried out for 40 hours to 44 hours, pH value is adjusted to be 7.4 to 7.6 until fermentation is finished; and dissolved oxygen during the whole fermentation process is controlled to be 30 percent to 50 percent. The technique adopted by the invention has total fed sorbin with a concentration of 10.5 percent to 11.5 percent (W/V) at the end of fermentation; the concentration of gulonic acid of fermentation solution is raised by 10 percent to 15 percent; the conversion rates of alcohol and acid are respectively promoted by 3 percentage points; and stability is good; besides, the technique process has simple and convenient operation and is easy for wide application.
Owner:DSM JIANGSHAN PHARMACEUTICAL (JIANGSU) CO LTD

Gene capable of regulating and controlling inhibition of vitamin C fermented strain acid production during acid stress

The invention relates to a gene capable of regulating and controlling inhibition of vitamin C fermented strain acid production during acid stress and belongs to the technical fields of basic research on vitamin C prepared by fermentation and biological engineering. The key gene for regulating and controlling yield reduction of acid stress induced 2-Keto-L-Gulonic acid (2-KLG) in the production strains is determined, so a metabolic engineering strategy with high pertinence is generated. The expression condition of genes, in particular membrane transport protein genes, of acid-forming bacteria in the vitamin C mixed bacteria fermented system is analyzed by an expression profile chip technology. Compared with ketogenic gulonic acid bacteria subjected to single cultivation, the ketogenic gulonic acid bacteria subjected to mixed bacteria cultivation have 45 upregulated membrane transport protein genes and 15 down regulated membrane transport protein genes. The notable thing is that: 7 iron ion transport protein genes are inhibited to express. After acid stress, the iron ion transport protein genes are over expressed. During fermentation, the iron ions are added to inhibit mixed bacteria to ferment and generate acid. The result shows that the iron ion transport protein exerts reverse action in the process of yield reduction of 2-KLG generated by the acid stress induced mixed bacteria fermentation.
Owner:JIANGNAN UNIV

Strain for producing 2-keto-L-gulonic acid and production method thereof

The invention belongs to the field of microbial fermentation, relates to a strain for producing 2-keto-L-gulonic acid and a production method of the strain, and in particular relates to a strain and process for converting a substrate namely L-sorbose into 2-keto-L-gulonic acid (2-KLG) by using a biological fermentation method. According to the strain disclosed by the invention, a new strain SPUB-003 which is stable in genetic character, can grow independently, and can be used for producing 2-KLG is obtained by separating and screening from soil and further performing artificial domestication. SPUB-003 is authenticated to be Ketogulonicigenium sp, and has been sent to General microorganism center of China Committee for Culture Collection of Microorganisms (CGMCC) for collection, wherein the collection date is July 3, 2013, and the collection number is CGMCC No.7876. SPUB-003 can perform independent growth and acid production at 20-34 DEG C; the strain can be used for independently producing 2-KLG by virtue of liquid state fermentation; after performing shake-flask fermentation for 24-96 hours, the conversion rate of obtained 2-KLG can be more than 70%; after fermenting for 24-68 hours by using a 5L fermentation tank, the conversion rate of 2-KLG can reach more than 80%. In a fermentation process, by adding micro physiological active substances, the conversion rate can be increased to more than 90%, and the fermentation period can be shortened.
Owner:SHENYANG PHARMA UNIVERSITY

Method for concentrating, crystallizing and recovering vitamin C mother liquor

The invention relates to a method for concentrating, crystallizing and recovering vitamin C mother liquor in a concentration and crystallization technology of the vitamin C mother liquor. The method comprises the following steps: performing decompression, evaporation and concentration on the vitamin C mother liquor in an evaporator, wherein the concentration condition is characterized in that the relative vacuum degree is greater than or equal to 0.092MPa, when the content ratio of 2-keto-L-gulonic acid to vitamin C in the vitamin C mother liquor is less than or equal to 1.13, concentrating the vitamin C mother liquor to vitamin C under a quasi stabilization zone under the concentration condition, concentrating the vitamin C mother liquor to 2-keto-L-gulonic acid under a quasi stabilization zone under the concentration condition; when the content ratio of 2-keto-L-gulonic acid to vitamin C in the vitamin C mother liquor is less than or equal to 1.13, adding the vitamin C mother liquor in continuous flow, concentrating to a terminal point, filtering, and recovering to obtain the vitamin C crystals. The method solves the problems that the esterification conversion reaction of the 2-keto-L-gulonic acid on industrial production of vitamin C is stable, when the content of 2-keto-L-gulonic acid in the vitamin C mother liquor is high, recovery rate through concentration and crystallization of the vitamin C mother liquor is low, and the crystallization recovery rate of the vitamin C mother liquor is influenced, and the production cost is increased.
Owner:NORTHEAST PHARMA GRP

Single-strain preparation and fermentation technology based on fermentation of 2-keto-L-gulonic acid

The invention provides a single-strain preparation and fermentation technology based on the fermentation of 2-keto-L-gulonic acid. According to the technology, in the strain preparation and fermentation process, the bacillus megatherium and the ketogulonicigenium vulgaer are separately cultured, the bacillus megatherium is cultured in a liquid medium until reaching the end point so as to obtain the cell lysis solution for standby use; and the independently stored ketogulonicigenium vulgaer is sequentially activated and cultured, and isolated and screened, and is continuously inoculated to an inclined surface to enlarge in cultivation together with seed solution, and then is transferred into a fermentation medium to ferment. The bacillus megatherium is respectively added to the culture at each level, of the ketogulonicigenium vulgaer based on the 3 to 30% of the inoculum size, so that the normal growth and metabolism of the ketogulonicigenium vulgaer is promoted. By adopting the technology, the negative effect of a large strain to a small strain during mixing the large strain with the small strain to culture and ferment in the conventional technology can be avoided, the benefits are provided for genetic improvement, screening, culturing and storage of the small strain and management in the strain growth and metabolism process, and the fermentation period is reduced.
Owner:DSM JIANGSHAN PHARMACEUTICAL (JIANGSU) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products